Synthetic Biology and Active Pharmaceutical Ingredients Act

Hozzl · 2024-01-25T20:00:21Z

Explore the details of House Bill 6897 Synthetic Biology and Active Pharmaceutical Ingredients Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on Health. Stay informed on legislative developments.

1/25/2024, 8:00 PM

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 6897

Bill HR 6897 is currently in the status of Bill Introduced since December 22, 2023. Bill HR 6897 was introduced during Congress 118 and was introduced to the House on December 22, 2023. Bill HR 6897's most recent activity was Referred to the House Committee on Armed Services. as of December 22, 2023

Bipartisan Support of Bill HR 6897

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 6897

Primary Policy Focus

Health

Alternate Title(s) of Bill HR 6897

Synthetic Biology and Active Pharmaceutical Ingredients Act

To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.